Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-Aventis allergy drug approved for pediatric use
The approval was for treatment of seasonal allergies and provides a treatment option that is non-impairing to pediatric populations as young as two years old. “Until now, parents
The approval was for treatment of seasonal allergies and provides a treatment option that is non-impairing to pediatric populations as young as two years old. “Until now, parents
The new grant is in three annual payments of $1.5 million and will support collaborative work with Johns Hopkins University, University of Pittsburgh and CONRAD, a cooperating agency
Clinical Data's intent is to develop a therapeutic diagnostic for a response to rituximab in the treatment of non-Hodgkin's lymphoma. Rituximab is approved for use in the treatment
For this study, MediVas utilized its synthetic subunit vaccine which provides an alternative to traditional egg-based vaccines. The vaccine used the company's patented biodegradable polymer technology. This technology
The new version of Seroquel is a sustained release formula aimed at giving a therapeutically effective dose by the second day of treatment. The submission will cover all
Sanofi Pasteur said that the vaccine induces antibodies that neutralize these additional strains which were recently discovered and not included in the original vaccine formulation. “Improving the repertoire
The information is designed to help people with long-term conditions such as cancer, or mental health problems, as patients only remember on average 10% of consultations, according to
In a primate trial conducted at the federal Centers for Disease Control and Prevention SIGA-246 protected cynomolgus monkeys from smallpox disease following intravenous high dosing with the smallpox
The approval marks the tenth indication for Taxotere which is already approved for a number of cancers including breast cancer, non-small cell lung cancer and prostate cancer. The
Auxilium has said that it plans to reallocate resources to its lead development project, AA4500, indicated for the treatment of Dupuytren's Contracture, a thickening of skin on the